{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-022427","form_type":"8-K","ticker":"ECOR","cik":"0001560258","company_name":"electroCore, Inc.","filed_at":"2025-08-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.349197+00:00","generated_at":"2026-05-17T19:25:12.500308+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"electroCore Q2 2025 revenue up 20% to $7.4M; net loss widens to $3.7M; raises $7.2M debt","bullets":["Net sales $7.4M in Q2 2025, up 20% YoY ($6.1M); YTD sales $14.1M up 22%.","GAAP net loss $3.7M ($0.44 loss per share) vs $2.7M ($0.38 loss) in Q2 2024.","Cash and securities $7.4M at June 30; raised $7.2M via term debt on Aug 4, 2025.","Full year 2025 revenue guidance ~$30.0M; net cash usage remainder of year $3.9-4.4M.","VA Rx gammaCore sales up 13% to $5.2M; Truvaga up 74% to $994K; Quell VA added $114K."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-022427","json":"https://secwatch.observer/filing/0001641172-25-022427.json","markdown":"https://secwatch.observer/filing/0001641172-25-022427.md","text":"https://secwatch.observer/filing/0001641172-25-022427.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1560258/000164117225022427/0001641172-25-022427-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1560258/000164117225022427/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T19:25:12.500308+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}